Technique for Iliopsoas Ultrasound-Guided Active Electromyography-Directed Botulinum A Toxin Injection in Cerebral Palsy

Symptomatic hip flexion deformity secondary to iliopsoas spasticity may interfere with gait, impair sitting balance, or contribute to hip subluxation or dislocation. A nonsurgical, minimally invasive technique to ameliorate iliopsoas spasticity is presented. The technique uses intramuscular injections of botulinum A toxin to provide selective neuromuscular blockade of the iliacus or psoas muscles or both. Because of the anatomic location of the target muscles, this technique uses ultrasound guidance for needle placement. Active electromyographic stimulation is used to verify the needle position adjacent to active myoneural interfaces. The authors' experience to date includes the treatment of 28 patients (53 hips). Use of this technique has resulted in improved hip range of motion. No intraoperative or postoperative adverse events or complications have been observed.

[1]  J. Reimers The stability of the hip in children. A radiological study of the results of muscle surgery in cerebral palsy. , 1980, Acta orthopaedica Scandinavica. Supplementum.

[2]  L. A. Koman,et al.  Management of Cerebral Palsy with Botulinum‐A Toxin: Preliminary Investigation , 1993, Journal of pediatric orthopedics.

[3]  L. A. Koman,et al.  Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. , 1994, Journal of pediatric orthopedics.

[4]  P. Grimaud [Cerebral palsy]. , 1972, Pediatrie.

[5]  S. Keats,et al.  A simple anteromedial approach to the lesser trochanter of the femur for the release of the iliopsoas tendon. , 1967, The Journal of bone and joint surgery. American volume.

[6]  Van Heest Ae Applications of botulinum toxin in orthopedics and upper extremity surgery. , 1997 .

[7]  E B Carpenter Role of Nerve Blocks in the Foot and Ankle in Cerebral Palsy: Therapeutic and Diagnostic , 1983, Foot & ankle.

[8]  Stuart L. Weinstein,et al.  Lovell and Winter's Pediatric Orthopedics , 1996 .

[9]  I. Jonkers,et al.  A multilevel approach to botulinum toxin type A treatment of the (ilio)psoas in spasticity in cerebral palsy , 1999 .

[10]  A. L. Albright,et al.  Intrathecal baclofen for spasticity in cerebral palsy. , 1991, JAMA.

[11]  E. B. Carpenter,et al.  Intramuscular Alcohol as an Aid in Management of Spastic Cerebral Palsy , 1980, Developmental medicine and child neurology.